NCT06916910Active, not recruiting
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors: A Multicenter Retrospective Clinical Study
Source: ClinicalTrials.gov · Last updated 8 Apr 2025
Brief summary (registry, in English)
In this study, we plan to explore the risk factors closely related to the occurrence of urinary leakage after partial nephrectomy for renal hilum tumors through retrospective analysis of multicenter clinical data, thereby providing clinical guidance value for the prevention of postoperative urinary leakage.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 24 Feb 2025
- Start date
- 18 Sept 2024
- Primary completion date
- 18 Sept 2025
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Diseases
- Childhood cancers
- NCT number
- NCT06916910
What you commit to
- Study type: Observational
- Planned participants: 200
- From 18 Sept 2024 to the primary completion date, 18 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient has surgical contraindications;
- The patient has received relevant treatments that may affect the results of this study, such as radiotherapy in the kidney area, a history of kidney surgery, etc.;
Other illness
- There are congenital malformations of the urinary system, obstructive nephropathy, or other diseases that seriously affect the function of the urinary system before surgery;
Other
- There are tumors in both kidneys.
Who the study is looking for
- CT or MRI angiography indicates a renal hilum tumor, and the patient has undergone partial nephrectomy;
- The Eastern Cooperative Oncology Group (ECOG) performance status score is between 0 and 1, and the age is between 18 and 75 years old;
- The clinicopathological data are complete;
- There is no infection, autoimmune disease, hematological disease, or other malignancies.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| first hospital affiliated of Fujian medical university Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.